Beneficial effects of combination therapy on cholesterol
AssigneePfizer Inc.
InventorsKeith Stuart Kanik, Samuel H. Zwillich, Mary Gardiner Boy
Life of this patent
Estimating the term…
Abstract
The present invention discloses pharmaceutical combination therapies for the treatment or prevention of diseases in a mammal comprising a Janus Kinase inhibitor or a pharmaceutically acceptable salt thereof and a HMG-CoA reductase inhibitor or a pharmaceutically acceptable salt thereof. Pharmaceutical compositions containing the same and kits for achieving a therapeutic effect in a mammal comprising pharmaceutical combination therapies are further described.
Claims18
A pharmaceutical combination therapy for the treatment or prevention of a disease in a mammal comprising:
- a Janus Kinase inhibitor or a pharmaceutically acceptable salt thereof;
- and
- a HMG-CoA reductase inhibitor or a pharmaceutically acceptable salt thereof.
A kit for achieving a therapeutic effect in a mammal comprising:
- a therapeutically effective amount of a Janus Kinase inhibitor or a pharmaceutically acceptable salt thereof;
- and
- a therapeutically effective amount of a HMG-CoA reductase inhibitor or a pharmaceutically acceptable salt thereof;
- and
- a container.
Dependencies are inferred from the claim text.